Pharming Group Announces Third Quarter 2008 Results

Marketwire -- Leiden, The Netherlands, October 17, 2008. Biotech company Pharming Group NV ("Pharming" or "the Company") (NYSE Euronext: PHARM) announced today its results for the first nine months of 2008 ended September 30, 2008. The financial results are in line with previously reported quarterly results while significant progress has been achieved in the review and approval process of Pharming's lead product Rhucin®.
MORE ON THIS TOPIC